A

  • Aarabi, Mohammad Hadi Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Abadi Marand, Laleh Effect of dynamic neuromuscular stabilization on fatigue and spasticity in people with multiple sclerosis: a randomized controlled trial (ORP-37) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abbasi, H. Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abin, Ahmad Ali The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abna, Zohreh Patient monitoring during treatment with natalizumab (ORP-24) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abolhasani, Javad Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
  • Abolhasani, Maryam Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abolhasani, Maryam MS and exercise (PP-23) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abrishamchi, Fatemeh Headache first manifestation of Multiple Sclerosis (PP-19) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Abuga, Imran Autonomic dysfunction and fatigue in Parkinson’s disease: a report from Kenya [Volume 2, Issue 1, 2023, Pages 47-50]
  • Aderinto, Nicholas Exploring the Potential of Biomarkers for Early Diagnosis and Management of Sporadic Creutzfeldt - Jakob disease; A Review [Volume 2, Issue 2, 2023, Pages 78-86]
  • Adibi, Armin A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Adibi, Iman Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Adibi, Iman Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Adibi, Iman A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Adibi, Iman Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Adibi, Iman Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Adibi, Iman Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Afshari-Safavi, Alireza Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Aghsaeifard, Masoud Ophthalmology in multiple sclerosis (ORP-47) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ahadiat, Seyed-Amirabbas Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
  • Ahadiat, Seyed Amir Abbas Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
  • Ahmadi, Maryam Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ahmadikhonsaraki, Elahe Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Alaie, Shekoofeh Lower urinary tract dysfunction in Multiple Sclerosis, Updates (ORP-31) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Alayi, Shokoufeh Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Alilou, Sanam Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Alizadeh Amiri, Ali System biology review of multiple sclerosis and discovery of drug targets (ORP-54) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Amiri Gheshlaghi, Saeed Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
  • Asadi, Bahador Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
  • Asadi-Pooya, Ali Akbar Management of seizure in patients with multiple sclerosis (ORP-51) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Asadollahzadeh, Elnaz Escalation or high-efficacy disease-modifying therapies in multiple sclerosis [Volume 2, Issue 2, 2023, Pages 106-108]
  • Asadollahzadeh, Elnaz Advanced imaging for multiple sclerosis (ORP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Asadollahzadeh, Elnaz Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran [Volume 3, Issue 1, 2024, Pages 1-2]
  • Ashtari, Fereshteh Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ashtari, Fereshteh Comorbidity in patients with MS (ORP-19) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ashtari, Fereshteh Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ashtari, Fereshteh Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ashtari, Fereshteh A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ashtari, Fereshteh Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, Among Iranian Patients (PP-05) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ashtari, Fereshteh Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ataei, Mitra Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Atafo, Gregory Imoukhuede An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
  • Azadbakht, Javid Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Azami, Mobin Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
  • Azami, Mobin Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
  • Azarsa, Mohammad Hassan New Technological Approach to Physical Therapy in Patients with Multiple Sclerosis (ORP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Azimi, Elham Sadat Neurosarcoidosis in an adult man with a family history of MS: A Case report (PP-26) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Azimzadeh, Kiarash Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Azizabadi Farahani, Maryam Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]

B

  • Baghalha, Fatemeh Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Baghbanian, Mohammad Treatment escalation vs early high efficacy treatment in multiple sclerosis (cons and pros) (ORP-45) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Bahrami, K. Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Balabandian, Mohammad Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
  • Balabandian, Mohammad Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Balabandian, Mohammad Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
  • Balabandian, Mohammad The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine [Volume 3, Issue 1, 2024, Pages 3-11]
  • Beladi Moghadam, Nahid Optic neuritis updates (ORP-57) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Biswas, Nistara Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]

C

  • Chalabianloo, Gholamreza Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
  • Chitsaz, Ahmad Paroxysmal Events in Multiple Sclerosis (MS); Pseudoathetosis as a Presenting Symptom of MS (ORP-48) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

D

  • Daneshvar, Sam Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran [Volume 3, Issue 1, 2024, Pages 1-2]
  • Davarpanah Jazi, Amirhossein Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Dehghani, Sara Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Doddamani, Rakesh Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]

E

  • Ebadi, Zahra Physical disability assessment: EDSS calculation (ORP-05) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ebrahimi, Narges Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ebrahimian, Mahboubeh Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Eidi, Atefeh Review of McDonald criteria (ORP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Emami, Ali Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Emami, Sepideh Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
  • Eshaghian-Dorcheh, Azam Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Eskandarieh, Sharareh Epidemiological view of national MS registry in Iran (NMSRI) (ORP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ezenwoba, Chidiogo An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]

F

  • Fallahi, Mohammad Sadegh Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Faraji, Ali Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Fatemi, Behzad A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Foroughipour, Mohsen Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

G

  • Ghabel Damirchi, Behnam Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
  • Ghaderi, Ali Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
  • Ghaffari, Mehran Update on inflammation, neurodegeneration and immunoregulation in MS (ORP-44) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ghalamkari, Arshia Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ghalamkari, Arshia Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ghanaati, Hossein Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
  • Ghannadi, Shima Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Gharemani, Amir Ali Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study (PP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Gholamzad, Amir Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Gholamzad, Mehrdad Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Golezar, Mohammad Hossein Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Golipoor, Farhad MS Prodrome; Is it a fact? (ORP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

H

  • Habibzadeh, Adrina Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Haghshenas Jazi, Mahbobeh Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
  • Hajmanouchehri, Reza Multiple Sclerosis (MS) and Legal Medical Doctrines (ORP-60) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Halabchi, Farzin MS and exercise (PP-23) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hamed, Zahra Typical MRI lesions of multiple sclerosis in the brain and spinal cord (ORP-13) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hantooshzadeh, Sedigheh Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Hashemi, Hassan Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Hashemi, Razieh Investigating the relationship between stress, anxiety and depression with the quality (PP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hashemi, Sana The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hashemi, Seyedeh Melika Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Hassani, Sara Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
  • Heidari, Hora Multiple sclerosis, infectious and Gastrointestinal complications (ORP-39) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Heidari, Hora Multiple sclerosis, Pregnancy, Breastfeeding (ORP-40) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Heydari, Sanaz A middle-aged woman with history of Multiple sclerosis presented with sub-acute encephalopathy (ORP-58) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hoseini, Aref The outcomes of physical activity and health education on cognition level in sedentary seniors [Volume 1, Issue 1, 2022, Pages 32-33]
  • Hoseini Nejad Mir, Nahid Patients monitoring during treatment with Teriflunomide (ORP-41) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hosseini, Ruhollah Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
  • Hosseini, Samaneh Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hosseini, Sayed Mohsen Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Hosseini, Seyed Armit Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Hosseinian, Zeinab Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
  • Hosseinian, Zeinab Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]

I

  • Ifemeje, Anthonia An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
  • Ighodaro, Osasumwen Eseosa An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]

J

  • Jafari, Majid Investigating the relationship between stress, anxiety and depression with the quality (PP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Jafarlou, Fatemeh Benign Paroxysmal Positioning Vertigo in Multiple Sclerosis (PP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Jafarlou, Fatemeh The Effect of Multiple Sclerosis on Peripheral Audio-Vestibular System (PP-17) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Jamali, Raika Multiple sclerosis and viral hepatitis (ORP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Jameie, Seyed Behnamedin Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease [Volume 1, Issue 1, 2022, Pages 21-27]

K

  • Kamalakannan, Anupam Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]
  • Kamali, Hoda Diagnostic approach to autoimmune encephalitis (ORP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • KamaliZonouzi, Sara Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Kamrani, Shirin Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Karimi, Zahra Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Karimi, Zahra Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kavosh, Aryan Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kazemi, Mohamad Ali Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Kazemzadeh, Kimia Artificial intelligence in multiple sclerosis imaging: advancements, benefits, and challenges (PP-07) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kazemzadeh, Kimia Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kazemzadeh, Kimia The Role of Artificial Intelligence in Depression Diagnosis, Prognosis, and Treatment: Gaps and Future Directions [Volume 3, Issue 1, 2024, Pages 20-21]
  • Khalili, Elham Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Khatibi, Mahsa Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Khodkam, Maedeh Neuroimmunoactive biomaterial design [Volume 1, Issue 1, 2022, Pages 17-18]
  • Khodkam, Maedeh Neuroinflammation and Neurodegenerative disease [Volume 1, Issue 1, 2022, Pages 19-20]
  • Khodkam, Maedeh Infant frontal EEG asymmetry and prenatal depression: Letter [Volume 1, Issue 1, 2022, Pages 37-38]
  • Khodkam, Maedeh Guillain-Barré syndrome in remission of Ulcerative colitis: a case report [Volume 2, Issue 1, 2023, Pages 13-15]
  • Khodkam, Maedeh Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Khonche, Sajad Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Khorshidi, Mohammad sadegh Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
  • Khosravi, Atoosa Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kouchaki, Ebrahim Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
  • Kouchaki, Ebrahim MS Variants (ORP-38) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kouchaki, Ebrahim The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Kumar Vats, Dimple Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]

L

  • Lawal, Abdulwahab An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
  • Lotfizadeh, Masoud Investigating the relationship between stress, anxiety and depression with the quality (PP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

M

  • Maghbooli, Zhila Reduction in Circulating Vitamin D Binding Protein in Patients with Multiple sclerosis (ORP-59) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mahyad, Mahshid Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mahyad, Mahshid Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Malek Zadeh, Mohammadreza Demyelinating Disease Following Anti-TNFa Treatment (Adalimumab) in Patients with psoriasis: A Case Report (PP-13) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Malek Zadeh, Mohammadreza Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mallahzadeh, Arashk The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine [Volume 3, Issue 1, 2024, Pages 3-11]
  • Masoud, Seyed-Ali Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
  • Masoud, Seyed-Ali Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
  • Mehdipour, Roshanak Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, Among Iranian Patients (PP-05) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mehrabi, Soraya Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
  • Mehrkian, Saeideh The importance of vestibular evaluation and rehabilitation in improving the balance in MS patients (ORP-04) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mirmosayyeb, Omid Optical Coherence Tomography (OCT) Measurements and Disability in Multiple Sclerosis (MS): Protocol of Systematic Review [Volume 2, Issue 1, 2023, Pages 44-46]
  • Mirmosayyeb, Omid Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
  • Mirmosayyeb, Omid Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mirmosayyeb, Omid Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mirzaasgari, Zahra Neurology Letters is born! [Volume 1, Issue 2, 2022, Pages 47-47]
  • Mirzaasgari, Zahra Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
  • Moases Ghaffary, Elham Optical Coherence Tomography (OCT) Measurements and Disability in Multiple Sclerosis (MS): Protocol of Systematic Review [Volume 2, Issue 1, 2023, Pages 44-46]
  • Moases Ghaffary, Elham Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
  • Moases Ghaffary, Elham Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Moases Ghaffary, Elham Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Moeini, Omid Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Moghadasi, Mehdi MS and Environmental Factors (ORP-61) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mohaghegh, Maryam Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mohammadi, Mobin The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine [Volume 3, Issue 1, 2024, Pages 3-11]
  • Mokary, Yousef Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mokary, Yousef Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mokary, Yousef Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Moradi, Behnaz Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Motahharynia, Ali A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Motamed, Mohammadreza Multiple sclerosis and legal medicine (ORP-34) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Motamedi-Jahromi, Aria Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report [Volume 1, Issue 1, 2022, Pages 34-36]
  • Mousavi, Taraneh A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mousavian, Pourandokht Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Mozhdehipanah, Hossein Everything we need to know about vaccination in MS (ORP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

N

  • Nabavi, Seyed Massood Horizons of MS therapy: during 30 years (ORP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nabizadeh, Fardin What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease? [Volume 1, Issue 1, 2022, Pages 1-11]
  • Nabizadeh, Fardin Biomaterials in The Treatment of Amyotrophic Lateral Sclerosis [Volume 1, Issue 1, 2022, Pages 12-16]
  • Nabizadeh, Fardin Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease [Volume 1, Issue 1, 2022, Pages 21-27]
  • Nabizadeh, Fardin Neurology Letters is born! [Volume 1, Issue 2, 2022, Pages 47-47]
  • Nabizadeh, Fardin Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
  • Nabizadeh, Fardin Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Nabizadeh, Fardin Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
  • Nabizadeh, Fardin COVID-19 vaccine-hesitancy is associated with lower cortical volume in elderly individuals [Volume 2, Issue 1, 2023, Pages 35-41]
  • Nabizadeh, Fardin Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
  • Nabizadeh, Fardin Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nabizadeh, Fardin Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Naghavi, Saba Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Naghavi, Saba Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Naghavi, Saba Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Naghavi, Saba Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nahayati, Mohammadali Treatment approach in Autoimmune encephalitis (ORP-36) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nahayati, Mohammad Ali Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nahayati, Mohammad Ali Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nahayati, Mohammad Ali Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nahayati, Mohammad-Ali Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Najafi, Mohammad Amin Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Najafi, Mohammad Amin Acute disseminated encephalomyelitis (ADEM), Report A Rare Case of Refractory form to treatment (PP-03) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Najafi, Mohammad Reza EEG Patterns in MS-related epilepsy A literature Review (ORP-26) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Namvari, Alireza Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
  • Nankali, Alireza Femoral head AVN concept and treatments (ORP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Naser Moghadasi, Abdorreza Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Naser Moghadasi, Abdorreza Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nasibi, Seyede Maryam Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
  • Navardi, Samira Optic neuritis and autoimmune optic neuropathies (ORP-35) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nejadghaderi, Seyed Aria Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
  • Niakosari, Vida The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nikfar, Shekoufeh A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nikkhah, Karim Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Niknam, Zahra Mind and Art (ORP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nikoo, Zahra Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Nourikhani, Mohammadmatin Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Nwakama, Chijindu An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
  • Nyundo, Jasmit Autonomic dysfunction and fatigue in Parkinson’s disease: a report from Kenya [Volume 2, Issue 1, 2023, Pages 47-50]

O

  • Olatunji, Gbolahan Exploring the Potential of Biomarkers for Early Diagnosis and Management of Sporadic Creutzfeldt - Jakob disease; A Review [Volume 2, Issue 2, 2023, Pages 78-86]
  • Oyungu, Juzar Autonomic dysfunction and fatigue in Parkinson’s disease: a report from Kenya [Volume 2, Issue 1, 2023, Pages 47-50]

P

  • Panahi, Delaram Guillain-Barré syndrome in remission of Ulcerative colitis: a case report [Volume 2, Issue 1, 2023, Pages 13-15]
  • Pandian, Preethi Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]
  • Pang, Sen The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis [Volume 2, Issue 1, 2023, Pages 25-29]
  • Pathak, Lokesh Personalized Treatment for Multiple Sclerosis: The Role of Precision Medicine [Volume 2, Issue 1, 2023, Pages 30-34]
  • Paybast, Sepideh How to estimate the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis? (ORP-43) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Paybast, Sepideh Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Payere, Maryam Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Pirahesh, Kasra Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report [Volume 1, Issue 1, 2022, Pages 34-36]
  • Pirahesh, Kasra Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Pirzad, Razieh Multidisciplinary rehabilitative management (PP-24) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Pourakbar, Ebrahim Acute disseminated encephalomyelitis following vaccination against SARS-cov-2: a case report (PP-04) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Pourmohammadi, Ahmad Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Pourmohammadi, Ahmad Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Pourmohammadi, Ahmad A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Pourmohammadi, Ahmad Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Poursadeghfard, Maryam The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Poursadeghfard, Maryam Definition and treatment of the multiple sclerosis relapse (ORP-10) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Poursadeghfard, Maryam Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

R

  • Rafiei, Nazanin Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
  • Rahmati, Ali Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rahmatian, Aryobarzan Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
  • Ramazani, Neda Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ramezani, Neda Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Ramezannezhad, Elham Role of Biomaterials in treatment of Alzheimer’s disease: A literature review [Volume 1, Issue 2, 2022, Pages 64-68]
  • Ramezannezhad, Elham Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rashidi Alavijeh, Mehran Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rasouli, Kimia The outcomes of physical activity and health education on cognition level in sedentary seniors [Volume 1, Issue 1, 2022, Pages 32-33]
  • Razazian, Nazanin Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Reza, Mohammad Amin Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rezaeimanesh, Nasim Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Rezaeimanesh, Nasim A narrative review on the dietary interventions in multiple sclerosis (ORP-03) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rezaeimanesh, Nasim Nutritional recommendations in multiple sclerosis patients: a narrative review (ORP-46) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rizvi, Priya Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
  • Roozbeh, Mehrdad Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Rostami, Mahya Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Rostami, Mohammad Reza Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]

S

  • Sadeghi, Hadis Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
  • Sadeghi, Mehdi Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Saeidi, Morteza Gut-Brain axis and MS: Is this true? (ORP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Safa, Nasim The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sahraian, Mohammad Ali A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sanati, Mohammad Hossein Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sanayei, Mehdi A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sanayei, Mehdi Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sayadnasiri, Mohammad Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
  • Sedighi, Behnaz Women and Multiple Sclerosis (ORP-07) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sedighi, Mohsen Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
  • Sehgal, Debabrata Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
  • Seyedesfahani, Behrad Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
  • Shaafi, Sheida Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
  • Shafiee, Mohammad Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Shafiei, Seyyed Hossein Femoral head AVN concept and treatments (ORP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shahmaei, Vahid The Role of Advanced MRI Techniques and Artificial Intelligence-based Methods In Diagnosis of Multiple Sclerosis (ORP-42) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shahzadi, Sohrab The role of stereotactic biopsy in atypical brain lesions (ORP-52) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shakiba, Shima Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
  • Shamlou, Farid Lingual dystonia as the first manifestation of multiple sclerosis (PP-22) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shams, Shirin Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sharafi, Amir Mohammad Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
  • Shaygannejad, Aysa Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shaygannejad, Vahid Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shaygannejad, Vahid A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shaygannejad, Vahid Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shaygannejad, Vahid Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shiati, Samin Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shirazi, Mahboobeh Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Shokri Shakib, Soheil Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Shreyashi, Gunjan Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
  • Shriati, Mohammad Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Sodeifian, Fatemeh Juvenile amyotrophic lateral sclerosis in 16 years old girl with HIV [Volume 1, Issue 1, 2022, Pages 44-46]
  • Sodeifian, Fatemeh Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
  • Sodeifian, Fatemeh Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
  • Soleimani, Mohammad Femoral head AVN concept and treatments (ORP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

T

  • Tabibian, Farinaz Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Tabrizi, Nasim Cardiovascular autonomic dysfunction in MS (PP-10) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Taghdisi Kashani, Alireza Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Talebi, Mahnaz MS and cognition: review of clinical, neuro-radiological features, and treatment (ORP-18) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

V

  • Vafaei, Seyedeh Maryam Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
  • Vaheb, Saeed Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

W

  • Wang, Hairui Current understanding of the association between Amyotrophic lateral sclerosis and frontotemporal dementia: Letter to Editor [Volume 2, Issue 1, 2023, Pages 42-43]
  • Wen-Yi, Jing The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis [Volume 2, Issue 1, 2023, Pages 25-29]

Y

  • Yazdani, Sara Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Yazdan Panah, Mohammad Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Yazdan Panah, Mohammad Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Yazdan Panah, Mohammad Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Yousefipour, Gholamali Case presentation, Atypical imaging of MS (PP-11) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Yousefi Pour, Ali Patients monitoring during treatment with Dimethyl fumarate (ORP-23) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]

Z

  • Zaer Rezaei, Hanieh Care ethics and empathic Practices in dealing with MS Patients (ORP-62) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Zafari, Rasa Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
  • Zandieh, Ghazal Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Zare Bidoki, Fatemeh Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
  • Zarvani, Ashraf Cardiovascular autonomic dysfunction in MS (PP-10) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
  • Zeinali, Marjan Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
  • Zhang, Jie Current understanding of the association between Amyotrophic lateral sclerosis and frontotemporal dementia: Letter to Editor [Volume 2, Issue 1, 2023, Pages 42-43]
  • Zi, Wu The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis [Volume 2, Issue 1, 2023, Pages 25-29]
  • Ziaee, Mahsa Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]